These final results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the strategy of targeting ACKR3 as a unique strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related disorders.Gene expression Assessment unveiled